- Tytuł:
- Abrocitinib 100 mg Once Daily for Moderate-to-Severe Atopic Dermatitis: A Review of Efficacy and Safety, and Expert Opinion on Use in Clinical Practice.
- Autorzy:
- Źródło:
- Dermatology & Therapy. Sep2023, Vol. 13 Issue 9, p1893-1907. 15p.
Czasopismo naukowe